The amino acid building blocks your purity test might miss

Most peptide researchers think in terms of twenty building blocks. Amino acids (the small chemical units that make up peptides and proteins) come in a standard set of twenty, and that set sits behind every sequence you buy, reconstitute, or run on a column. A new preprint from a team of researchers just showed that the real chemistry goes further than that mental model. The team found ways to expand special bacterial enzymes called nonribosomal peptide synthetases (NRPS) so they could use unusual, non-standard amino acids, known as non-canonical amino acids (ncAAs). The result: new peptides built inside living bacteria, with extra chemical changes made directly in the bacterial broth without even pulling the compound out first.

That matters for anyone sourcing compounds made this way, because it changes what "purity" and "identity" actually mean when you read an analytical certificate.

What NRPS machinery actually does

Most proteins are built by ribosomes, which are tiny cellular machines that read genetic instructions (called mRNA) and string together the standard 20 amino acids. NRPS enzymes work completely differently. Think of them as a factory assembly line encoded in the DNA of bacteria and fungi. Each station on the line handles one amino acid: one part (called the A-domain, or adenylation domain) picks the right amino acid, a second part holds it in place, and a third part links it onto the growing chain. The stations fire one after another, and out comes a finished peptide, with no ribosome needed at all.

Nature already uses this system to slip unusual chemistry into peptides. More than 300 unusual building blocks, including many ncAAs, show up in naturally made NRP compounds. Vancomycin, for example, carries residues (individual amino acid units in the chain) that have been chlorinated (a chlorine atom added), hydroxylated (an oxygen and hydrogen atom added), and cross-linked (bonded together in a ring). Cyclosporin contains amino acids with an extra methyl group attached to the nitrogen atom. Daptomycin uses an amino acid called kynurenine that you would not find in a standard peptide. These tweaks explain why these compounds behave so differently from ordinary peptides, in terms of how long they last, how they bind to targets, and how tough they are chemically.

Engineering the A-domain to expand the substrate set

The research team's key move was to search through many NRPS systems and find A-domains (the amino acid-picking parts) that would accept unusual ncAAs instead of just the standard ones. Then they transplanted those tolerant A-domains into other NRPS frameworks, like swapping out a part on one assembly line and installing it on a different line. This is genuinely hard to do, because A-domains are finely tuned and swapping them can break the protein's shape. The team got around that by searching broadly and carefully choosing which parts to transplant, creating hybrid enzymes that build peptide sequences the original bacteria never made on their own.

After the enzyme did its job, the team went one step further. They ran additional chemical reactions directly in the raw bacterial extract, without isolating the peptide first. Think of it like seasoning a soup while it is still in the pot, rather than pulling each ingredient out to season it separately. Doing the chemistry in the crude extract shortens the process and keeps the compound in a protective environment while reactive chemical groups are being modified. By combining NRPS assembly with post-assembly chemistry on the whole extract, the team created a much wider variety of structures than either step could produce alone.

Why ncAAs change how a peptide behaves at the bench

A non-canonical amino acid is not just an odd naming choice. It changes the molecule in ways that show up directly in your work:

• Protease resistance: Proteases are enzymes that chop up peptides. D-amino acids (mirror-image versions of normal amino acids), beta-amino acids (amino acids with a slightly different backbone shape), and N-methylated residues (amino acids with an extra methyl group on the nitrogen) are poorly recognized by common proteases. A peptide built with these residues may stay intact under conditions that would destroy a standard chain, which shifts the stability timeline and affects how many freeze-thaw cycles your reconstituted stock can handle.
• Solubility and aggregation: Non-standard side chains (the parts of an amino acid that stick out from the backbone and give it its character) change how well the peptide mixes with water and how its electrical charges are distributed. A peptide with an ncAA in a key position may behave differently in bacteriostatic water versus other diluents (liquids used to dissolve it), or may clump together at concentrations a standard peptide would handle without any problem.
• Mass spectrometry identity: Mass spectrometry (MS) is a lab method that identifies a molecule by measuring its mass and how it breaks apart into smaller pieces. ncAAs produce different fragment masses than their standard counterparts. If you run an HPLC-MS trace (a test that separates a sample and measures the mass of each part) and compare the result against a predicted sequence built only from the 20 standard amino acids, any ncAA in the actual peptide will show up as a mass that does not match. That mismatch is either a sign of a purity problem or evidence that what you dissolved is structurally different from what the certificate describes.

Reading the vial more carefully

For researchers sourcing NRP-derived compounds, or any peptide where the full synthesis route is not disclosed, the analytical certificate deserves a close look. Molecular weight confirmation by MS is the starting point. Fragment pattern analysis (looking at how the molecule breaks apart under MS) and amino acid composition testing give you residue-level identity, meaning you can check which building blocks are actually in the chain. If the certificate does not say how the peptide was made and does not include a fragmentation spectrum (the detailed mass fingerprint from breaking the molecule apart), then the structural certainty of what you are dissolving is lower than the headline purity number suggests.

Storage also warrants attention when ncAAs are involved. Greater resistance to proteases does not automatically mean the compound is stable against oxidation (reaction with oxygen), light exposure, or freeze-thaw cycling. Store reconstituted stocks at -20°C or colder, aliquot (divide) them into single-use volumes where possible, and keep the compound in glass rather than plastic. Unusual side chains can stick to polypropylene (a common plastic) surfaces and reduce the actual concentration in your working stock before you run a single experiment.

The NRPS engineering approach in this preprint points toward a growing number of structurally diverse peptides that sit outside conventional sequence space. Whether you encounter these as research targets or as unknowns in a poorly characterized source product, the actual residue-level structure can differ from what your HPLC peak and expected mass together imply. Knowing that this chemistry exists is the first step to accounting for it in your work.

Prompted by this coverage at bioRxiv →

Related from our lab: the pen · cartridges · bacteriostatic water · reconstitution calculators

Shared by PreppinPeppers for research, educational, and demonstration awareness only. We link to third-party coverage; we do not endorse it, and nothing here is medical advice or a recommendation to use any substance in humans or animals. Our products are sold for laboratory research use only.

Frequently asked questions

What are non-canonical amino acids (ncAAs) in peptide research?

ncAAs are residues outside the standard 20, including D-amino acids, beta-amino acids, and chemically modified variants (methylated, halogenated, hydroxylated). NRPS machinery and post-assembly chemistry can incorporate them, altering mass, stability, and binding properties.

How do NRPS enzymes differ from ribosomal peptide synthesis?

NRPS enzymes are modular, ribosome-independent assembly lines encoded in bacterial or fungal DNA. Each module selects and condenses one amino acid, including non-standard ones, via adenylation, thiolation, and condensation domains, producing structurally diverse peptides.

Why might a standard HPLC or mass spec purity test miss ncAAs in an NRP compound?

Reference libraries and fragmentation databases are calibrated for canonical residues. Unusual residues shift molecular mass and elution time; post-assembly modifications add further complexity, requiring tailored analytical methods for accurate identity confirmation.

What the research community gets wrong about NRPS peptides and non-canonical amino acids

• Assuming the standard 20 is the whole story. Many researchers read a certificate as if a peptide can only contain the canonical amino acids. NRPS assembly lines routinely install residues outside that set, so a mass predicted from the standard 20 can be off before you ever open the vial.
• Treating a high purity number as confirmed identity. A purity percentage tells you how much of one peak is present. It does not tell you which residues are actually in the chain. Two different structures can both look clean on the same trace.
• Reading a matching mass as a matching structure. Different combinations of residues can land near the same molecular weight. Without a fragmentation spectrum, a mass that matches your expected sequence is suggestive, not proof, that the residues are what the label says.
• Confusing protease resistance with general stability. A D-amino acid or an N-methylated residue can shrug off enzymes and still be sensitive to oxygen, light, and freeze-thaw at the bench. Resistance to one kind of breakdown says nothing about the others.
• Assuming "made in bacteria" means a clean, fully described route. Post-assembly chemistry run in crude extract can add modifications that standard reference libraries were never set up to expect, so an unremarkable HPLC peak can still hide an unusual residue.

From our bench: If you have run an NRP-derived or ncAA-containing peptide on HPLC-MS at your own bench, we want to hear the observed monoisotopic mass alongside the mass you predicted from the listed sequence, and whether a fragmentation spectrum backed up the residue assignment. Tell us the diluent and the container you used (glass versus polypropylene), and report only numbers you actually measured. We will not publish estimates or filled-in values.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. UniProt P0C061 , Gramicidin S synthase 1 (NRPS, D-phenylalanine adenylation), Aneurinibacillus migulanus
5. PubChem CID 14969 , Vancomycin (nonribosomal glycopeptide with modified residues)
6. PubChem CID 21585658 , Daptomycin (nonribosomal lipopeptide containing kynurenine)